NCT01007591

A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas

Calcipotriol Plus Hydrocortisone in Paediatric Patients (Aged 6 to 17 Years) With Psoriasis Vulgaris on the Face and on the Intertriginous Areas

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: LEO Pharma · Industry
• Sex: All
• Age: 6 Years – 17 Years
• Healthy volunteers: Not accepted

Summary

An international, multi-centre, prospective, randomised, double-blind, active-controlled, 2-arm, parallel group, 8-week, phase 3 clinical study in paediatric patients (aged 6 to 17 years) with psoriasis vulgaris on the face and on the intertriginous areas

Conditions

• Psoriasis Vulgaris

Interventions

Type	Name	Description
DRUG	LEO 80190	Applied once daily
DRUG	Hydrocortisone	Applied once daily

Timeline

• Start date: 2009-10-01
• Primary completion: 2010-06-01
• Completion: 2010-12-01
• First posted: 2009-11-04
• Last updated: 2025-03-07
• Results posted: 2019-01-15

Locations

1 site across 1 country: France